Skip to content

Two new NNRTIs look promising in early clinical trials

SMART study and 54-trial pooled analysis produce conflicting data about abacavir heart attack link

Men more likely to drop out of clinic care than women in western Kenya

How does abacavir/3TC compare to tenofovir/FTC? ACTG5202 and GSK studies disagree

Urine biomarkers may predict cardiovascular disease in people taking antiretroviral therapy

Treatment as prevention tool: enough evidence to say it works, says IAS president

Two novel immune therapies in early investigation: autologous dendritic cells and CD4 zeta gene-modified T cells

Tenofovir kidney toxicity most likely with high blood pressure medications and PIs

AIDS in 2031: where will we be?